Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.
NCT03529292
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Skin Aging
Interventions
DEVICE:
AmeaCell
Sponsor
Symbioken